Georges Gemayel, Director at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 17,772 shares at $31.33 ($557K) on 2024-09-13, disclosed to the SEC on 2024-09-17.
Open-market sale of $557k SUPN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.33 | 3,886 | $122K | 21.9% |
| 2 | $31.33 | 3,886 | $122K | 21.9% |
| 3 | $31.33 | 10,000 | $313K | 56.3% |
| Total | $31.33 avg | 17,772 | $557K | 100% |
| Filing → |
| SUPN | SELL | 2024-11-08 | $1.0M | — | Filing → |
| MNTA | SELL | 2020-08-07 | $330K | — | Filing → |
| MNTA | SELL | 2020-07-30 | $300K | — | Filing → |